70.22
前日終値:
$68.73
開ける:
$69
24時間の取引高:
425.44K
Relative Volume:
0.78
時価総額:
$2.02B
収益:
$234.60M
当期純損益:
$-13.23M
株価収益率:
-134.88
EPS:
-0.5206
ネットキャッシュフロー:
$19.61M
1週間 パフォーマンス:
+13.02%
1か月 パフォーマンス:
+8.35%
6か月 パフォーマンス:
+120.47%
1年 パフォーマンス:
+293.17%
Anaptysbio Inc Stock (ANAB) Company Profile
名前
Anaptysbio Inc
セクター
電話
858-362-6295
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Compare ANAB vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ANAB
Anaptysbio Inc
|
70.22 | 2.02B | 234.60M | -13.23M | 19.61M | -0.5206 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.28 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
828.35 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
310.00 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-06-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2024-12-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-12-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-07-22 | 開始されました | H.C. Wainwright | Buy |
| 2024-07-19 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-04-16 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Wells Fargo | Overweight |
| 2024-03-12 | アップグレード | Wedbush | Neutral → Outperform |
| 2024-02-26 | 開始されました | BTIG Research | Buy |
| 2024-02-21 | 開始されました | Stifel | Buy |
| 2024-02-16 | 開始されました | Piper Sandler | Overweight |
| 2023-05-22 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-05-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-09-13 | ダウングレード | Truist | Buy → Hold |
| 2022-09-01 | 開始されました | Raymond James | Outperform |
| 2022-03-22 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-06-22 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-21 | 開始されました | UBS | Neutral |
| 2021-03-16 | アップグレード | Truist | Hold → Buy |
| 2021-03-09 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-03-08 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2021-02-11 | アップグレード | JP Morgan | Underweight → Overweight |
| 2020-10-27 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-10-14 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-11-08 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2019-11-08 | ダウングレード | Jefferies | Buy → Hold |
| 2019-11-08 | ダウングレード | SunTrust | Buy → Hold |
| 2019-11-08 | ダウングレード | Wedbush | Outperform → Neutral |
| 2019-06-21 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | ダウングレード | Stifel | Buy → Hold |
| 2018-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-21 | 開始されました | JP Morgan | Overweight |
| 2018-07-19 | 開始されました | Credit Suisse | Outperform |
| 2018-04-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | 繰り返されました | Stifel | Buy |
| 2018-03-06 | 繰り返されました | Stifel | Buy |
| 2018-02-15 | 繰り返されました | SunTrust | Buy |
| 2018-01-23 | 繰り返されました | Credit Suisse | Outperform |
| 2017-11-15 | 開始されました | SunTrust | Buy |
| 2017-11-09 | 開始されました | Jefferies | Buy |
| 2017-10-11 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Anaptysbio Inc (ANAB) 最新ニュース
JPMorgan Chase Reduces Stake in AnaptysBio Biotech Firm - National Today
AnaptysBio, Inc. $ANAB Shares Sold by JPMorgan Chase & Co. - MarketBeat
Aug Macro: Can AnaptysBio Inc reach all time highs this year2026 Trading Recap & Real-Time Price Movement Reports - baoquankhu1.vn
Anaptys to spin-off First Tracks Biotherapeutics, announces $100M buyback - MSN
ANAPTYSBIO INC- W/I (ANABV) Stock Chart - ChartMill
ANABV Technical Analysis | Trend, Signals & Chart Patterns | ANAPTYSBIO INC- W/I (NASDAQ:ANABV) - ChartMill
AnaptysBio stock hits 52-week high at 68.46 USD By Investing.com - Investing.com Australia
AnaptysBio (NASDAQ:ANAB) Hits New 1-Year HighTime to Buy? - MarketBeat
AnaptysBio stock hits 52-week high at 68.46 USD - Investing.com
Equity in earnings of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Pretax income of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Total equity of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Total assets of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Net debt of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Balance Sheet – NASDAQ:ANABV - TradingView — Track All Markets
After tax other income/expense of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Behavioral Patterns of ANAB and Institutional Flows - Stock Traders Daily
ANABV Price Today: AnaptysBio, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
Return on assets % of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Asset turnover of AnaptysBio, Inc. – NASDAQ:ANABV - tradingview.com
Quick ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Book value per share of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Current ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Enterprise value to EBITDA ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Debt to assets ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Price to cash flow ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Price to book ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
EBITDA margin % of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio: Upside Constrained By Undifferentiated Data, Legal Uncertainties - Seeking Alpha
Debt to equity ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Enterprise value of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Statistics – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Earnings and Revenue – NASDAQ:ANABV - TradingView — Track All Markets
ANABV Price Today: AnaptysBio, Inc. Stock Price, Quote & Chart - MEXC
ANABV interactive stock chart | ANAPTYSBIO INC stock - Yahoo Finance Singapore
AnaptysBio, Inc. Income Statement – NASDAQ:ANABV - TradingView — Track All Markets
Free float of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Basic earnings per share (basic EPS) of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Dividends – NASDAQ:ANABV - TradingView — Track All Markets
Trade Alert: Independent Director Of AnaptysBio John Schmid Has Sold Stock - simplywall.st
AnaptysBio, Inc.: Target Price Consensus and Analysts Recommendations | ANABV | US0327242055 - marketscreener.com
Price performance - Yahoo Finance Singapore
Risk On: Will AnaptysBio Inc face regulatory challengesPortfolio Return Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
AnaptysBio (NASDAQ:ANAB) Trading Up 7.6%Still a Buy? - MarketBeat
AnaptysBio, Inc. (ANAB) stock price, news, quote and history - Yahoo Finance UK
Spin-off Imminent At AnaptysBio - San Diego Business Journal
AnaptysBio, Inc. Common Stock When Issued (ANABV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB) - The Globe and Mail
Assessing AnaptysBio (ANAB) Valuation After New US$100 Million Buyback And Cancelled Equity Offerings - Yahoo Finance
J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $69 - Moomoo
Director Susannah Gray at AnaptysBio (ANAB) submits initial Form 3 - Stock Titan
Anaptysbio Inc (ANAB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):